Opus Pharmaceuticals

Opus Pharmaceuticals is a South African, family-owned pharmaceutical company established in 1990. The company appears to focus primarily on marketed gastrointestinal products, with Kantrexil tablets and suspension positioned as its flagship prescription brand for the treatment of specific and non-specific gastroenteritis. Publicly available information suggests Opus is a commercial-stage specialty pharma business rather than a clinical-development biotech, with limited evidence of a broader R&D pipeline. Its business profile centers on branded pharmaceutical products and patient information services in South Africa, particularly in gut health.